Last action was on 9-4-2025
Current status is Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View Official Bill Information at congress.govNo users have voted for/against support on this bill yet. Be the first!
This Act may be cited as the "Epinephrine’s Pharma Inflated Price Ends Now Act" or the "EPIPEN Act".
(a) PHSA - Part D of title XXVII of the Public Health Service Act (42 U.S.C. 300gg–111 et seq.) is amended by adding at the end the following new section:
(a) In general - A group health plan, and a health insurance issuer offering group or individual health insurance coverage, shall provide coverage of epinephrine delivery systems, and with respect to such delivery systems, may not—
(1) - apply any deductible; or
(2) - impose any cost sharing in excess of $60 per package of 2 delivery systems (or the equivalent).
(b) Application of cost sharing toward deductibles and out-of-Pocket maximums - Any cost-sharing payments made pursuant to shall be counted toward any deductible or out-of-pocket maximum that applies under the plan or coverage.
(c) Out-of-Network providers - Nothing in this section requires a plan or issuer that has a network of providers to provide benefits for an epinephrine delivery system described in this section that is delivered by an out-of-network provider, or precludes a plan or issuer that has a network of providers from imposing higher cost sharing than the levels specified in for an epinephrine delivery system described in this section that is delivered by an out-of-network provider.
(d) Epinephrine delivery system defined - In this section, the term epinephrine delivery system means a delivery system approved by the Food and Drug Administration for the administration of epinephrine, including any auto-injector, nasal spray, or sublingual delivery system that is so approved.
(b) ERISA -
(1) In general - Subpart B of part 7 of subtitle B of title I of the Employee Retirement Income Security Act of 1974 (29 U.S.C. 1185 et seq.) is amended by adding at the end the following new section:
(a) In general - A group health plan, and a health insurance issuer offering group health insurance coverage, shall provide coverage of epinephrine delivery systems, and with respect to such delivery systems, may not—
(1) - apply any deductible; or
(2) - impose any cost sharing in excess of $60 per package of 2 delivery systems (or the equivalent).
(b) Application of cost sharing toward deductibles and out-of-Pocket maximums - Any cost-sharing payments made pursuant to shall be counted toward any deductible or out-of-pocket maximum that applies under the plan or coverage.
(c) Out-of-Network providers - Nothing in this section requires a plan or issuer that has a network of providers to provide benefits for an epinephrine delivery system described in this section that is delivered by an out-of-network provider, or precludes a plan or issuer that has a network of providers from imposing higher cost sharing than the levels specified in for an epinephrine delivery system described in this section that is delivered by an out-of-network provider.
(d) Epinephrine delivery system defined - In this section, the term epinephrine delivery system means a delivery system approved by the Food and Drug Administration for the administration of epinephrine, including any auto-injector, nasal spray, or sublingual delivery system that is so approved.
(2) Clerical amendment - The table of contents in section 1 of the Employee Retirement Income Security Act of 1974 (29 U.S.C. 1001 et seq.) is amended by inserting after the item relating to section 725 the following:
(c) IRC -
(1) In general - Subchapter B of chapter 100 of the Internal Revenue Code of 1986 is amended by adding at the end the following new section:
(a) In general - A group health plan shall provide coverage of epinephrine delivery systems, and with respect to such delivery systems, may not—
(1) - apply any deductible; or
(2) - impose any cost sharing in excess of $60 per package of 2 delivery systems (or the equivalent).
(b) Application of cost sharing toward deductibles and out-of-Pocket maximums - Any cost-sharing payments made pursuant to shall be counted toward any deductible or out-of-pocket maximum that applies under the plan.
(c) Out-of-Network providers - Nothing in this section requires a plan that has a network of providers to provide benefits for an epinephrine delivery system described in this section that is delivered by an out-of-network provider, or precludes a plan that has a network of providers from imposing higher cost sharing than the levels specified in for an epinephrine delivery system described in this section that is delivered by an out-of-network provider.
(d) Epinephrine delivery system defined - In this section, the term epinephrine delivery system means a delivery system approved by the Food and Drug Administration for the administration of epinephrine, including any auto-injector, nasal spray, or sublingual delivery system that is so approved.
(2) Clerical amendment - The table of sections for subchapter B of chapter 100 of the Internal Revenue Code of 1986 is amended by adding at the end the following new item:
(d) Effective date - The amendments made by this section shall apply with respect to plan years beginning on or after January 1, 2026.